Philippe Guy, experienced pharmaceutical industry strategist, becomes Chairman of the supervisory board of MedinCell – 03/13/2024 at 6:30 p.m.


• Philippe Guy led the Healthcare Practice department and served on the executive committee of the Boston Consulting Group (BCG)

• He has advised numerous pharmaceutical and biotechnology companies of international scope on a wide range of subjects such as the definition of global strategies or at business unit level, the optimization and organization of R&D processes, implementation strategies in the market, or even large-scale transformations and post-merger/acquisition integrations.

• Philippe Guy actively participated in the growth of MedinCell as a board member, chairman of the audit committee during and after the IPO, and promoter of the inclusion of sustainable practices at the board level with the creation of the ESG committee, which he continues to lead.

• As president, he will use his vast experience to support management in the definition and implementation of MedinCell’s strategy.

To receive all financial information from MedinCell in real time, request it by email to [email protected]. Your registration will be immediate.



Source link -86